# FDA Inspection 1243354 - Headquarters, US Army Medical Research & Development Command IRB - June 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/headquarters-us-army-medical-research-development-command-irb/26453467-cd8d-4e1c-b26f-90084f9bf4e2
Source feed: FDA_Inspections

> FDA Inspection 1243354 for Headquarters, US Army Medical Research & Development Command IRB on June 26, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1243354
- Company Name: Headquarters, US Army Medical Research & Development Command IRB
- Inspection Date: 2024-06-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1243354 - 2024-06-26](https://www.keypedia.com/records/fda_inspections/headquarters-us-army-medical-research-development-command-irb/ae686161-2fca-433f-8871-e6073c300357)
- [FDA Inspection 1243354 - 2024-06-26](https://www.keypedia.com/records/fda_inspections/headquarters-us-army-medical-research-development-command-irb/2bda3d42-959b-4365-95b4-7e72b91047b3)
- [FDA Inspection 1052452 - 2018-05-01](https://www.keypedia.com/records/fda_inspections/headquarters-us-army-medical-research-development-command-irb/cfaf73b1-588d-4f8d-9296-bfb681687c81)

Company: https://www.keypedia.com/companies/headquarters-us-army-medical-research-development-command-irb/6b661f3a-e66e-4048-b45b-8a2fda434ec7